This post is from a low-reputation account and contains an unverified outbound link. Be cautious before clicking external links.
Millions of people throughout the world are affected by chronic hepatitis C, which, if left untreated, can frequently result in serious liver issues. However, the landscape of hepatitis C therapy has changed dramatically in recent years as a result of the creation and use of direct-acting antiviral (DAA) medicines.